Literature DB >> 17554057

Rapid generation of a functional NK-cell compartment.

Martin Prlic1, Daisuke Kamimura, Michael J Bevan.   

Abstract

Bone marrow transplants are an important therapeutic tool for treating certain types of cancer as well as genetic diseases affecting the hematopoietic system. Until the transferred stem cells differentiate and reconstitute the immune system, recipients are at increased risk from opportunistic infections. We report the rapid generation of a functional natural killer (NK) compartment in lethally irradiated mice that received bone marrow cells from a syngeneic donor by treatment with IL-2/anti-IL-2 antibody complexes. We demonstrate that IL-2 complexes specifically expand the donor but not the host NK population and discuss the implications of this finding in the context of graft-versus-host disease and tumor relapse. Finally, we show that NK cells rapidly generated by IL-2 complexes kill MHC class I-deficient cells effectively in vivo. These data underline the unique therapeutic potential of IL-2 complexes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17554057      PMCID: PMC1976371          DOI: 10.1182/blood-2007-04-086108

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  20 in total

1.  Converting IL-15 to a superagonist by binding to soluble IL-15R{alpha}.

Authors:  Mark P Rubinstein; Marek Kovar; Jared F Purton; Jae-Ho Cho; Onur Boyman; Charles D Surh; Jonathan Sprent
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-06       Impact factor: 11.205

2.  Immunology. An antibody paradox, resolved.

Authors:  Martin Prlic; Michael J Bevan
Journal:  Science       Date:  2006-03-31       Impact factor: 47.728

Review 3.  Activation and self-tolerance of natural killer cells.

Authors:  Stephan Gasser; David H Raulet
Journal:  Immunol Rev       Date:  2006-12       Impact factor: 12.988

4.  IL-2 in vivo activities and antitumor efficacy enhanced by an anti-IL-2 mAb.

Authors:  Daisuke Kamimura; Yukihisa Sawa; Masae Sato; Eviryanti Agung; Toshio Hirano; Masaaki Murakami
Journal:  J Immunol       Date:  2006-07-01       Impact factor: 5.422

5.  Roles for common cytokine receptor gamma-chain-dependent cytokines in the generation, differentiation, and maturation of NK cell precursors and peripheral NK cells in vivo.

Authors:  Christian A J Vosshenrich; Thomas Ranson; Sandrine I Samson; Erwan Corcuff; Francesco Colucci; Eleftheria E Rosmaraki; James P Di Santo
Journal:  J Immunol       Date:  2005-02-01       Impact factor: 5.422

Review 6.  Immunobiology of allogeneic hematopoietic stem cell transplantation.

Authors:  Lisbeth A Welniak; Bruce R Blazar; William J Murphy
Journal:  Annu Rev Immunol       Date:  2007       Impact factor: 28.527

Review 7.  Natural killer cell immune responses.

Authors:  Wayne M Yokoyama
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

8.  Selective stimulation of T cell subsets with antibody-cytokine immune complexes.

Authors:  Onur Boyman; Marek Kovar; Mark P Rubinstein; Charles D Surh; Jonathan Sprent
Journal:  Science       Date:  2006-02-16       Impact factor: 47.728

9.  Dendritic cells prime natural killer cells by trans-presenting interleukin 15.

Authors:  Mathias Lucas; William Schachterle; Karin Oberle; Peter Aichele; Andreas Diefenbach
Journal:  Immunity       Date:  2007-03-29       Impact factor: 31.745

10.  Coordinate expression and trans presentation of interleukin (IL)-15Ralpha and IL-15 supports natural killer cell and memory CD8+ T cell homeostasis.

Authors:  Patrick R Burkett; Rima Koka; Marcia Chien; Sophia Chai; David L Boone; Averil Ma
Journal:  J Exp Med       Date:  2004-09-27       Impact factor: 14.307

View more
  6 in total

1.  Heat shock protein vaccination and directed IL-2 therapy amplify tumor immunity rapidly following bone marrow transplantation in mice.

Authors:  Robert G Newman; Michael J Dee; Thomas R Malek; Eckhard R Podack; Robert B Levy
Journal:  Blood       Date:  2014-03-31       Impact factor: 22.113

2.  NCI First International Workshop on The Biology, Prevention, and Treatment of Relapse After Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on the Biology Underlying Recurrence of Malignant Disease following Allogeneic HSCT: Graft-versus-Tumor/Leukemia Reaction.

Authors:  Jeffrey S Miller; Edus H Warren; Marcel R M van den Brink; Jerome Ritz; Warren D Shlomchik; William J Murphy; A John Barrett; Hans Jochem Kolb; Sergio Giralt; Michael R Bishop; Bruce R Blazar; J H Frederik Falkenburg
Journal:  Biol Blood Marrow Transplant       Date:  2010-02-10       Impact factor: 5.742

3.  Controlled Human Malaria Infection Leads to Long-Lasting Changes in Innate and Innate-like Lymphocyte Populations.

Authors:  Maxmillian Mpina; Nicholas J Maurice; Masanao Yajima; Chloe K Slichter; Hannah W Miller; Mukta Dutta; M Juliana McElrath; Kenneth D Stuart; Stephen C De Rosa; John P McNevin; Peter S Linsley; Salim Abdulla; Marcel Tanner; Stephen L Hoffman; Raphael Gottardo; Claudia A Daubenberger; Martin Prlic
Journal:  J Immunol       Date:  2017-06-02       Impact factor: 5.422

4.  CD25-Targeted IL-2 Signals Promote Improved Outcomes of Influenza Infection and Boost Memory CD4 T Cell Formation.

Authors:  Fahmida Alam; Ayushi Singh; Valeria Flores-Malavet; Stewart Sell; Andrea M Cooper; Susan L Swain; K Kai McKinstry; Tara M Strutt
Journal:  J Immunol       Date:  2020-05-06       Impact factor: 5.422

5.  Natural killer cell mediated missing-self recognition can protect mice from primary chronic myeloid leukemia in vivo.

Authors:  Mika Kijima; Noémie Gardiol; Werner Held
Journal:  PLoS One       Date:  2011-11-23       Impact factor: 3.240

6.  Regulatory T cells expressing granzyme B play a critical role in controlling lung inflammation during acute viral infection.

Authors:  J Loebbermann; H Thornton; L Durant; T Sparwasser; K E Webster; J Sprent; F J Culley; C Johansson; P J Openshaw
Journal:  Mucosal Immunol       Date:  2012-01-11       Impact factor: 7.313

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.